| # | Drug | Count |
|---|---|---|
| 0 | LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE | 105 |
| 1 | OMEPRAZOLE MAGNESIUM | 86 |
| 2 | LOPERAMIDE HYDROCHLORIDE | 77 |
| 3 | LEVOTHYROXINE SODIUM | 45 |
| 4 | OMEPRAZOLE | 43 |
| 5 | METFORMIN | 41 |
| 6 | NIRMATRELVIR AND RITONAVIR | 39 |
| 7 | ASPIRIN | 37 |
| 8 | ASPIRIN 325 MG | 36 |
| 9 | ASPIRIN 81 MG | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEDAZURIDINE AND DECITABINE | 5 | 0.0051 |
| 1 | ACORAMIDIS HYDROCHLORIDE | 1 | 0.0027 |
| 2 | IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE | 3 | 0.0024 |
| 3 | SUVOREXANT | 30 | 0.0023 |
| 4 | MITAPIVAT | 3 | 0.0023 |
| 5 | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | 2 | 0.0020 |
| 6 | BALOXAVIR MARBOXIL | 4 | 0.0017 |
| 7 | LOPERAMIDE HYDROCHLORIDE | 77 | 0.0017 |
| 8 | AVATROMBOPAG MALEATE | 4 | 0.0017 |
| 9 | ASENAPINE MALEATE | 14 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 59 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 57 |
| 2 | Proton Pump Inhibitor [EPC] | 47 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 38 |
| 4 | Corticosteroid [EPC] | 34 |
| 5 | Estrogen [EPC] | 31 |
| 6 | Benzodiazepine [EPC] | 30 |
| 7 | Orexin Receptor Antagonist [EPC] | 30 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 27 |
| 9 | Factor Xa Inhibitor [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 3 | 0.0023 |
| 1 | Orexin Receptor Antagonist [EPC] | 30 | 0.0016 |
| 2 | Provitamin D2 Compound [EPC] | 26 | 0.0009 |
| 3 | mu-Opioid Receptor Agonist [EPC] | 2 | 0.0007 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 5 | Sodium Channel Blocker [EPC] | 1 | 0.0006 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 6 | 0.0006 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |
| 8 | Nuclear Export Inhibitor [EPC] | 3 | 0.0003 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |